People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Epicore Biosystems, Inc. | — | Biotechnology | Series B | $37.1M | $151.3M | 2024 |
James J. Ryan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James J. Ryan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Rogers | 1 | 20 |
| John Wright | 1 | 5 |
| James Ryan | 1 | 4 |
| Laura Lang | 1 | 4 |
| Stephen Lee | 1 | 2 |
| Weihua J. Li | 1 | 1 |
| JEFF MODEL | 1 | 1 |
| Kimberly Querrey | 1 | 1 |
| Jeffrey J. Model | 1 | 1 |
| Roozbeh Ghaffari | 1 | 1 |
| Alexander J. Aranyosi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.